ATE322249T1 - System zur abgabe einer tobramycin-formulierung - Google Patents
System zur abgabe einer tobramycin-formulierungInfo
- Publication number
- ATE322249T1 ATE322249T1 AT02771857T AT02771857T ATE322249T1 AT E322249 T1 ATE322249 T1 AT E322249T1 AT 02771857 T AT02771857 T AT 02771857T AT 02771857 T AT02771857 T AT 02771857T AT E322249 T1 ATE322249 T1 AT E322249T1
- Authority
- AT
- Austria
- Prior art keywords
- delivery system
- formulation delivery
- tobramycin
- less
- tobramycin formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29223401P | 2001-05-18 | 2001-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE322249T1 true ATE322249T1 (de) | 2006-04-15 |
Family
ID=23123791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02771857T ATE322249T1 (de) | 2001-05-18 | 2002-05-17 | System zur abgabe einer tobramycin-formulierung |
Country Status (11)
Country | Link |
---|---|
US (8) | US20030143162A1 (de) |
EP (2) | EP2186508A3 (de) |
JP (2) | JP2004534763A (de) |
AT (1) | ATE322249T1 (de) |
AU (1) | AU2010210026A1 (de) |
CA (1) | CA2447600C (de) |
DE (1) | DE60210402T2 (de) |
DK (1) | DK1320355T3 (de) |
ES (1) | ES2261735T3 (de) |
PT (1) | PT1320355E (de) |
WO (1) | WO2002094217A1 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW465235B (en) | 1998-09-17 | 2001-11-21 | United Video Properties Inc | Electronic program guide with digital storage |
ATE322249T1 (de) * | 2001-05-18 | 2006-04-15 | Chiron Corp | System zur abgabe einer tobramycin-formulierung |
US20040022740A1 (en) * | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
WO2003015707A2 (en) * | 2001-08-20 | 2003-02-27 | Transave, Inc. | Method for treating lung cancers |
SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
US8245708B2 (en) * | 2002-05-07 | 2012-08-21 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
US7607436B2 (en) * | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
CN1681478A (zh) * | 2002-08-02 | 2005-10-12 | 川塞夫有限公司 | 铂聚集体及其制备方法 |
US9186322B2 (en) * | 2002-08-02 | 2015-11-17 | Insmed Incorporated | Platinum aggregates and process for producing the same |
AU2002953095A0 (en) * | 2002-11-29 | 2002-12-19 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
CA2801100A1 (en) | 2003-03-10 | 2004-09-23 | Optimer Pharmaceuticals, Inc. | Macrolides and processes for their preparation |
RU2341267C2 (ru) * | 2003-10-15 | 2008-12-20 | Пари Фарма Гмбх | Жидкий препарат, содержащий тобрамицин |
AU2005223654A1 (en) * | 2004-03-18 | 2005-09-29 | Transave, Inc. | Administration of cisplatin by inhalation |
US20070065522A1 (en) * | 2004-03-18 | 2007-03-22 | Transave, Inc. | Administration of high potency platinum compound formulations by inhalation |
PL1750667T3 (pl) * | 2004-05-17 | 2011-06-30 | Gilead Sciences Inc | Aerozolizowana kombinacja fosfomycyny/aminoglikozydu do leczenia bakteryjnych zakażeń oddechowych |
US20060034906A1 (en) * | 2004-05-21 | 2006-02-16 | Transave, Inc. | Treatment of lung diseases and pre-lung disease conditions |
NZ552047A (en) | 2004-06-18 | 2009-11-27 | Nektar Therapeutics | Method of treatment of endobronchial infections |
EP1811963A4 (de) * | 2004-11-08 | 2010-01-06 | Transave Inc | Verfahren zur krebsbehandlung mit intraperitoneal verabreichten platinverbindungsformulierungen auf lipidbasis |
CN101287446A (zh) * | 2005-09-29 | 2008-10-15 | 尼克塔治疗公司 | 抗生素制剂、单位剂量、试剂盒以及方法 |
AU2013206401B2 (en) * | 2005-09-29 | 2016-06-23 | Novartis Ag | Antibiotic formulations, unit doses, kits, and methods |
US9107824B2 (en) | 2005-11-08 | 2015-08-18 | Insmed Incorporated | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
US20070190182A1 (en) * | 2005-11-08 | 2007-08-16 | Pilkiewicz Frank G | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
US20070190180A1 (en) * | 2005-11-08 | 2007-08-16 | Pilkiewicz Frank G | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously |
WO2007056236A2 (en) * | 2005-11-08 | 2007-05-18 | Transave, Inc. | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously |
US20070122350A1 (en) * | 2005-11-30 | 2007-05-31 | Transave, Inc. | Safe and effective methods of administering therapeutic agents |
HUE029994T2 (en) | 2005-12-08 | 2017-04-28 | Insmed Inc | Lipid-based preparations of antinfectants for the treatment of lung infections |
US8337814B2 (en) * | 2005-12-15 | 2012-12-25 | Topical Sinus Therapeutics, Inc. | Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions |
JP2008199905A (ja) * | 2007-02-16 | 2008-09-04 | Snow Brand Milk Prod Co Ltd | 乳酸菌生残性向上剤 |
CN105732745A (zh) | 2007-10-25 | 2016-07-06 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
CN101981688B (zh) * | 2008-04-02 | 2014-04-02 | Imec公司 | 制造半导体器件的方法以及半导体器件 |
CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
WO2011032052A1 (en) | 2009-09-10 | 2011-03-17 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and mac diseases |
EP2550286B1 (de) | 2010-03-22 | 2015-12-09 | Cempra Pharmaceuticals, Inc. | Kristalline formen eines makrolids und verwendungen dafür |
PL2571506T3 (pl) | 2010-05-20 | 2017-10-31 | Cempra Pharmaceuticals Inc | Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich |
JP6000946B2 (ja) | 2010-07-12 | 2016-10-05 | クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS | 肺感染症の治療のための組成物 |
KR20180110181A (ko) | 2010-09-10 | 2018-10-08 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
US8826904B2 (en) | 2011-07-12 | 2014-09-09 | Cardeas Pharma Corporation | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
JP2014523909A (ja) | 2011-07-12 | 2014-09-18 | カーディアス ファーマ コーポレイション | 人工呼吸器関連肺炎(vap)及び人工呼吸器関連気管(vat)気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム |
IN2014DN08939A (de) | 2012-03-27 | 2015-05-22 | Cempra Pharmaceuticals Inc | |
GB201208080D0 (en) | 2012-05-09 | 2012-06-20 | Norton Healthcare Ltd | Tobramycin formulation |
CN115414384A (zh) | 2012-09-04 | 2022-12-02 | 埃莱森制药有限责任公司 | 用顺铂脂质复合物预防癌症的肺部复发 |
BR112015012351A8 (pt) | 2012-11-29 | 2019-10-01 | Insmed Inc | composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo |
MX360905B (es) | 2013-01-11 | 2018-11-21 | Xellia Pharmaceuticals Aps | Polimixinas, composiciones, metodos de preparacion y metodos de uso. |
AU2014239959A1 (en) | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
EP2968384A4 (de) | 2013-03-15 | 2017-02-15 | Cempra Pharmaceuticals, Inc. | Konvergente verfahren zur herstellung antibakterieller makrolidmittel |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
US10711040B2 (en) | 2014-07-09 | 2020-07-14 | Xellia Pharmaceuticals Aps | Low substituted polymyxins and compositions thereof |
US11033602B2 (en) | 2014-10-03 | 2021-06-15 | Xellia Pharmaceuticals Aps | Inhalation device |
SG11201702717XA (en) | 2014-10-03 | 2017-04-27 | Xellia Pharmaceuticals Aps | Compositions |
US10617703B2 (en) | 2014-12-10 | 2020-04-14 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US10898455B2 (en) | 2016-01-07 | 2021-01-26 | Cmpd Licensing, Llc | Urea cream formulations |
US11278590B2 (en) | 2015-08-05 | 2022-03-22 | Cmpd Licensing, Llc | Compositions and methods for treating nail infections |
US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11690815B2 (en) | 2015-08-05 | 2023-07-04 | Cmpd Licensing Llc | Hyperkeratotic skin condition treatments and compositions |
US10898491B2 (en) | 2015-12-18 | 2021-01-26 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11446236B2 (en) | 2015-08-05 | 2022-09-20 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
US9999604B2 (en) | 2016-11-17 | 2018-06-19 | Cmpd Licensing, Llc | Compounded solutions of diclofenac and lidocaine and methods |
US10525025B2 (en) | 2016-11-17 | 2020-01-07 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
JP7460534B2 (ja) | 2018-03-30 | 2024-04-02 | インスメッド インコーポレイテッド | リポソーム医薬品の連続製造方法 |
WO2020163416A1 (en) * | 2019-02-05 | 2020-08-13 | Mylan Inc | Devices and methods for tobramycin inhalation treatment |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3993223A (en) | 1974-07-25 | 1976-11-23 | American Home Products Corporation | Dispensing container |
US4502616A (en) | 1982-01-04 | 1985-03-05 | Health Care Concepts, Inc. | Single use vial |
GB8801655D0 (en) | 1988-01-26 | 1988-02-24 | Waverley Pharma Ltd | Ampoules |
EP0326529B1 (de) | 1988-01-28 | 1992-12-30 | Lameplast S.R.L. | Fläschchenkette für pharmazeutische, kosmetische und andere Produkte |
GB8802349D0 (en) | 1988-02-03 | 1988-03-02 | Waverley Pharma Ltd | Ampoule with luer |
DE3916840A1 (de) | 1988-09-21 | 1990-03-29 | Bernd Hansen | Ampulle |
US5409125A (en) | 1989-12-11 | 1995-04-25 | Aktiebolaget Astra | Unit dose container |
CA2027690A1 (en) | 1990-10-18 | 1992-04-19 | Christian Laing | Plastic ampul |
FR2687066A1 (fr) | 1992-02-06 | 1993-08-13 | Oreal | Ampoule autocassable. |
US5508269A (en) | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
US5758637A (en) * | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
CN1348377A (zh) * | 1998-12-17 | 2002-05-08 | 希龙公司 | 用气溶胶化的抗生素治疗严重慢性支气管炎(支气管扩张症)的方法 |
SE9902627D0 (sv) * | 1999-07-08 | 1999-07-08 | Siemens Elema Ab | Medical nebulizer |
DE19953317C1 (de) | 1999-11-05 | 2001-02-01 | Pari Gmbh | Inhalationsvernebler |
ATE322249T1 (de) | 2001-05-18 | 2006-04-15 | Chiron Corp | System zur abgabe einer tobramycin-formulierung |
-
2002
- 2002-05-17 AT AT02771857T patent/ATE322249T1/de active
- 2002-05-17 EP EP09015943A patent/EP2186508A3/de not_active Withdrawn
- 2002-05-17 DE DE60210402T patent/DE60210402T2/de not_active Revoked
- 2002-05-17 DK DK02771857T patent/DK1320355T3/da active
- 2002-05-17 ES ES02771857T patent/ES2261735T3/es not_active Expired - Lifetime
- 2002-05-17 WO PCT/US2002/015999 patent/WO2002094217A1/en active IP Right Grant
- 2002-05-17 JP JP2002590936A patent/JP2004534763A/ja active Pending
- 2002-05-17 CA CA2447600A patent/CA2447600C/en not_active Expired - Fee Related
- 2002-05-17 US US10/151,701 patent/US20030143162A1/en not_active Abandoned
- 2002-05-17 EP EP02771857A patent/EP1320355B1/de not_active Revoked
- 2002-05-17 PT PT02771857T patent/PT1320355E/pt unknown
-
2003
- 2003-12-22 US US10/743,529 patent/US6890907B2/en not_active Expired - Lifetime
-
2004
- 2004-07-01 US US10/883,143 patent/US20040265241A1/en not_active Abandoned
-
2005
- 2005-05-10 US US11/125,670 patent/US20050207987A1/en not_active Abandoned
- 2005-05-10 US US11/126,108 patent/US20050201947A1/en not_active Abandoned
-
2007
- 2007-10-24 US US11/923,486 patent/US7825095B2/en not_active Expired - Lifetime
-
2009
- 2009-08-07 JP JP2009185305A patent/JP2009269923A/ja active Pending
-
2010
- 2010-08-09 AU AU2010210026A patent/AU2010210026A1/en not_active Abandoned
- 2010-09-17 US US12/884,505 patent/US20110005518A1/en not_active Abandoned
-
2011
- 2011-11-14 US US13/295,228 patent/US8507454B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP2186508A2 (de) | 2010-05-19 |
US20110005518A1 (en) | 2011-01-13 |
CA2447600A1 (en) | 2002-11-28 |
DE60210402T2 (de) | 2006-12-07 |
CA2447600C (en) | 2015-10-20 |
US20120101055A1 (en) | 2012-04-26 |
US20050207987A1 (en) | 2005-09-22 |
ES2261735T3 (es) | 2006-11-16 |
WO2002094217A1 (en) | 2002-11-28 |
DE60210402D1 (de) | 2006-05-18 |
DK1320355T3 (da) | 2006-07-31 |
US8507454B2 (en) | 2013-08-13 |
EP1320355B1 (de) | 2006-04-05 |
EP2186508A3 (de) | 2010-08-25 |
JP2009269923A (ja) | 2009-11-19 |
US20040131555A1 (en) | 2004-07-08 |
AU2010210026A1 (en) | 2010-09-02 |
US20030143162A1 (en) | 2003-07-31 |
US7825095B2 (en) | 2010-11-02 |
PT1320355E (pt) | 2006-08-31 |
US20050201947A1 (en) | 2005-09-15 |
US20040265241A1 (en) | 2004-12-30 |
US20080095717A1 (en) | 2008-04-24 |
JP2004534763A (ja) | 2004-11-18 |
US6890907B2 (en) | 2005-05-10 |
EP1320355A1 (de) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE322249T1 (de) | System zur abgabe einer tobramycin-formulierung | |
WO2002043750A3 (en) | Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations | |
BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
NZ552047A (en) | Method of treatment of endobronchial infections | |
IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
BR0109875A (pt) | Tratamento de doenças respiratórias | |
EP0861667A3 (de) | Partikelförmige Mittel | |
MXPA03000353A (es) | Medicamentos para tratamiento quimioterapeutico de enfermedades. | |
MY144021A (en) | Pharmaceutical delivery system | |
AU6226090A (en) | Medicaments | |
MXPA03000321A (es) | Formulaciones de macrolido para inhalacion y metodos de tratamiento de infecciones endobronquiales. | |
MXPA05009629A (es) | Composiciones que contienen trospio. | |
BR9812553A (pt) | Formulação medicamentosa com liberação de substância ativa controlada | |
DK98089D0 (da) | Medikament-lipid-systemer med lav toxicitet | |
DK1673074T3 (da) | Flydende præparat, indeholdende tobramycin | |
WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
NO20041011L (no) | Inhaleringssammensetninger omfattende tricykliske 5,6-dihydro-9H-pyrazolo(3,4-C) -1,2,4-triazolo(4,3-alfa)pyridiner | |
AU2615795A (en) | Compounds and compositions for administration via oral inhalation or insufflation | |
AU2002236587A1 (en) | Compositions for adhesion prevention | |
WO2002074287A3 (en) | Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics | |
EP0753309A2 (de) | Lactoferrin (oder analoge Proteine) und Desferrioxamine-Methansulfonate (oder andere Metalionenchelaten) Zusammensetzung für Therapie von viralen infektiösen Krankheiten | |
ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
CN116437903A (zh) | 肝素组合物在通过吸入途径通过软雾吸入器或振动网状技术雾化器治疗病毒性肺病、急性和/或慢性肺病中的用途 | |
KR20090042507A (ko) | 돼지 위축성 비염의 예방 및 치료를 위해 아미카신 및 이의약제학적으로 허용가능한 염과, 베타-글루칸을 유효성분을포함하는 비강 분무용 조성물 | |
RU93003456A (ru) | Лекарственный препарат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1320355 Country of ref document: EP |